Rationale for the EUCAST clinical breakpoints

First Page		Document Content
Date: 2010-10-14 03:28:33 Gram-positive bacteria Alcohols Alkenes Fusidic acid Steroids Staphylococcus Antibiotic resistance Azithromycin Bacteria Microbiology Antibiotics		Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Download Document from Source Website File Size: 171,45 KB Share Document on Facebook

	Original Research Article In vitro evaluation of antibacterial activity of verbascoside, lemon verbena extract and caffeine in combination with gentamicin against drugresistant Staphylococcus aureus and Escherichia coli DocID: 1v3Be - View Document
	Exercise (a) Find the gene fdh in Staphylococcus aureus subsp. aureus N315. How many orthologues does it have? (b) Find the human orthologue. What is the target %id and the query %id? Why are these different? DocID: 1uZaI - View Document
	Original article \| Published 15 September 2016, doi:smwCite this as: Swiss Med Wkly. 2016;146:w14339 Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends fr DocID: 1uR3v - View Document
	COMMENT ON “ Evidence for the Absence of Staphylococcus aureus in the Land Applied Biosolids.” Rusin et al. (1 and in ref 2) dismissed processed sewage sludges as a source of Staphylococcus aureus infections a DocID: 1utHY - View Document
	Figure 1: MIS Library Comparison Chart For A Good Match For this high-match Strain A: CLIN40 Staphylococcus . . . . . . . . . . . . .0.762 DocID: 1tray - View Document